6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Chevron Introduces Next-gen Techron in U.S. Chevron and Texaco Gasolines
Just now	GreenPower Unveils Innovative Heating Solution for Type A Nano BEAST All-Electric, Purpose-Built, Zero-Emission School Bus
8m ago	Yapi ve Kredi Bankasi : Successful issuance of 500 million US$ perpetual Additional Tier 1 Capital Transaction
14m ago	Crown Castle Names Kris Hinson as Chief Commercial Officer and Mark Lennon as Chief Information Officer
18m ago	Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results

About

49.90USD+1.23 +2.53%

Closed • Updated at 13:35 GMT+00:00

Market Cap$12.54B

P/E Ratio16.54

Volume2.41M

Beta1.43

RSI60.26

Gross Margin96.44%

Health TechnologyPharmaceuticals: Major

Exelixis, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Exelixis Announces Clinical Development Collaboration with Merck for Phase 3 STELLAR-316 Pivotal Trial for Patients with Colorectal Cancer

Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May

Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate Update

Exelixis to Release First Quarter 2026 Financial Results on Tuesday, May 5, 2026

Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March

Community Chat

Ask AI